FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1052303004: Product containing atoltivimab and maftivimab and odesivimab in parenteral dose form (medicinal product form)


Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4279402019 Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form en Synonym Active Case insensitive SNOMED CT core
4279403012 Product containing atoltivimab and maftivimab and odesivimab in parenteral dose form (medicinal product form) en Fully specified name Active Case insensitive SNOMED CT core


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form Is a Atoltivimab- and maftivimab- and odesivimab-containing product true Inferred relationship Some
Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form Has manufactured dose form Parenteral dose form true Inferred relationship Some
Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form Plays role Antiviral therapeutic role true Inferred relationship Some
Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form Is a Product manufactured as parenteral dose form true Inferred relationship Some
Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form Has active ingredient Atoltivimab true Inferred relationship Some 1
Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form Has active ingredient Maftivimab true Inferred relationship Some 2
Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form Has active ingredient Odesivimab true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group
Atoltivimab and maftivimab and odesivimab only product in parenteral dose form Is a True Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form Inferred relationship Some

This concept is not in any reference sets

Back to Start